Skip to content
★ Sign in to follow
AJ

Abhijeet J. Lele

Agile Therapeutics IncStereotaxis, Inc.EP Medsystems Inc
Total declarations
39
Companies
3
▲ Purchases (22 ops.)
€175k
▼ Sales (0 ops.)
—

Latest filing published 01 Apr 2019 for Agile Therapeutics INC, €27k.

Filing timeline

BuySale
Abhijeet J. Lele

Insider track record

Disclosed buys
22
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
22
Positive at T+90
20%
Median T+90
-9.5%

Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 17 Nov 2008 · 6566 days ago · €756
    +19.9%
    Entry US$29.84 · Close at T+365 US$35.77
  • Filed 13 Mar 2008 · 6815 days ago · €68k
    +2.5%
    Entry US$32.48 · Close at T+365 US$33.30

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Abhijeet J. Lele: trading record in brief

Filings by Abhijeet J. Lele span 3 companies, the busiest being Stereotaxis, Inc., EP Medsystems Inc and Agile Therapeutics Inc. Between 5 June 2006 and 29 March 2019, the trades on record add up to 39 filings.

Every open-market trade on record is a purchase: 22 purchases worth €175k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 12 share grants and 1 option exercise. Since January 2019: 1 purchase and no sales on the market.

The median purchase comes to €2,561. Ninety days after publication, 10 purchases show a median change of -9.5%, with the price up in 20% of them. These figures describe past trades and do not predict future prices.

Most recently, on 1 April 2019, the filings show an open-market purchase worth €27k in Agile Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Abhijeet J. Lele

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total
  • ▲
    DirectorExecutivesAgile Therapeutics Inc
    30,800 USD31SEC
    20,000 shares@ US$1.54100.0% of flowCommon StockSEC:0001104659-19-018999:0
    Canonical exit: 27 Jun 2019 (T+90)
  • ◇
    DirectorExecutivesAgile Therapeutics Inc
    0SEC
    17,949 sharesCommon StockSEC:0001104659-18-039214:0
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    17,680 USD0SEC
    6,800 shares@ US$2.60Common StockSEC:0000950138-08-000846:0
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    1,032 USD0SEC
    400 shares@ US$2.58Common StockSEC:0000950138-08-000846:1
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    7,168 USD0SEC
    2,800 shares@ US$2.56Common StockSEC:0000950138-08-000846:2
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    20,750 USD0SEC
    8,300 shares@ US$2.50Common StockSEC:0000950138-08-000846:3
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    486 USD0SEC
    200 shares@ US$2.43Common StockSEC:0000950138-08-000846:4
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    2,420 USD0SEC
    1,000 shares@ US$2.42Common StockSEC:0000950138-08-000846:5
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    3,600 USD0SEC
    1,500 shares@ US$2.40Common StockSEC:0000950138-08-000846:6
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    956 USD0SEC
    400 shares@ US$2.39Common StockSEC:0000950138-08-000846:7
    Canonical exit: 15 Feb 2009 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    1,412 USD0SEC
    400 shares@ US$3.53Common StockSEC:0000950138-08-000215:0
    Canonical exit: 9 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesStereotaxis, Inc.
    104,784 USD0SEC
    29,600 shares@ US$3.54Common StockSEC:0000950138-08-000215:1
    Canonical exit: 9 Jun 2008 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    2,944 USD0SEC
    2,300 shares@ US$1.28Common stockSEC:0001181431-06-066027:0
    Canonical exit: 20 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    258 USD0SEC
    200 shares@ US$1.29Common stockSEC:0001181431-06-066027:1
    Canonical exit: 20 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    516 USD0SEC
    400 shares@ US$1.29Common stockSEC:0001181431-06-066027:2
    Canonical exit: 20 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    4,128 USD0SEC
    3,200 shares@ US$1.29Common stockSEC:0001181431-06-066027:3
    Canonical exit: 20 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    20,800 USD0SEC
    16,000 shares@ US$1.30Common stockSEC:0001181431-06-066027:4
    Canonical exit: 20 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    520 USD0SEC
    400 shares@ US$1.30Common stockSEC:0001181431-06-066027:5
    Canonical exit: 25 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    3,900 USD0SEC
    3,000 shares@ US$1.30Common stockSEC:0001181431-06-066027:6
    Canonical exit: 25 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    780 USD0SEC
    600 shares@ US$1.30Common stockSEC:0001181431-06-066027:7
    Canonical exit: 25 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    5,980 USD0SEC
    4,600 shares@ US$1.30Common stockSEC:0001181431-06-066027:9
    Canonical exit: 25 Feb 2007 (T+90)
  • ▲
    DirectorExecutivesEP Medsystems Inc
    6,579 USD0SEC
    5,100 shares@ US$1.29Common stockSEC:0001181431-06-066027:10
    Canonical exit: 25 Feb 2007 (T+90)
  • ◆
    DirectorExecutivesStereotaxis, Inc.
    85,488 USD0SEC
    10,946 shares@ US$7.81Common StockSEC:0000950138-06-000573:0
  • ◆
    DirectorExecutivesStereotaxis, Inc.
    89,596 USD0SEC
    11,472 shares@ US$7.81Common StockSEC:0000950138-06-000573:1
  • ◆
    DirectorExecutivesStereotaxis, Inc.
    568,138 USD0SEC
    72,745 shares@ US$7.81Common StockSEC:0000950138-06-000573:2

25 of 38 declarations